what changed for me between month 2 and month 11
Genuine question, and the title is the question: what changed for me between month 2 and month 11.
Added ApoB to the panel after a thread here. It told me something the standard lipid panel had been hiding.
My ApoB moved and I spent a fortnight convinced I knew why. The repeat six weeks later was back in range and I had changed nothing.
Tracked triglycerides against the weight trend for a year. The correlation was much weaker than I expected and that was worth knowing.
Not medical advice, obviously, and nothing here is approved for human use. One person with a spreadsheet.
best — the order this archive was captured in
Substantial weight loss independently moves lipids, liver enzymes and several other markers. Attributing a change to a compound while losing weight is confounded by design.
baseline before you start is worth more than any later panel
Right, and weight loss itself moves several markers, so attribution is harder than these threads assume.
ApoB counts atherogenic particles rather than the cholesterol they carry, which is why it can diverge from LDL-C and why it is the addition most worth making.
lab reference ranges are not treatment targets
lab reference ranges are not treatment targets
Adding the obvious one — take it to whoever ordered the panel. This board cannot read it for you.
Adding the obvious one — take it to whoever ordered the panel.
Agreed — and standardising the draw conditions is the cheapest improvement available.